Literature DB >> 2582414

Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III).

M G Sarngadharan, L Bruch, M Popovic, R C Gallo.   

Abstract

Antigenic cross-reactivity of human T-cell leukemia virus type III (HTLV-III) with HTLV-I and HTLV-II and other retroviruses was measured by using a stringent homologous competition radioimmunoassay for the Gag protein p24 and a less stringent electrophoretic transfer blot assay. In the competition radioimmunoassay only minimal cross-reactivities were detected between HTLV-III p24 and both HTLV-I and HTLV-II. No cross-reactivity was detected with any other retrovirus. In the electrophoretic transfer blot system using rabbit antibody to HTLV-I, HTLV-II, and HTLV-III, low-level cross-reaction was detected between HTLV-I and HTLV-III and between HTLV-II and HTLV-III. Unlike the cross-reactivity between HTLV-I p24 and HTLV-III p24, which was bidirectional, the one between HTLV-II and HTLV-III was only a one-way reactivity. Antiserum to HTLV-II recognized HTLV-III p24, but the antiserum to HTLV-III did not recognize HTLV-II p24. The results indicate that HTLV-III is a unique retrovirus with a limited homology with HTLV-I and HTLV-II but unrelated to most other retroviruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582414      PMCID: PMC397800          DOI: 10.1073/pnas.82.10.3481

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

2.  Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome.

Authors:  P M Feorino; V S Kalyanaraman; H W Haverkos; C D Cabradilla; D T Warfield; H W Jaffe; A K Harrison; M S Gottlieb; D Goldfinger; J C Chermann
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

3.  Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.

Authors:  S K Arya; R C Gallo; B H Hahn; G M Shaw; M Popovic; S Z Salahuddin; F Wong-Staal
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

4.  Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

Authors:  B Safai; M G Sarngadharan; J E Groopman; K Arnett; M Popovic; A Sliski; J Schüpbach; R C Gallo
Journal:  Lancet       Date:  1984-06-30       Impact factor: 79.321

5.  Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS.

Authors:  E Vilmer; F Barre-Sinoussi; C Rouzioux; C Gazengel; F V Brun; C Dauguet; A Fischer; P Manigne; J C Chermann; C Griscelli
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

6.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Authors:  V S Kalyanaraman; M G Sarngadharan; M Robert-Guroff; I Miyoshi; D Golde; R C Gallo
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

7.  Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV).

Authors:  P D Markham; S Z Salahuddin; V S Kalyanaraman; M Popovic; P Sarin; R C Gallo
Journal:  Int J Cancer       Date:  1983-04-15       Impact factor: 7.396

8.  Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus.

Authors:  M Popovic; G Lange-Wantzin; P S Sarin; D Mann; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  16 in total

1.  Multicenter evaluation of the novel ABN Western blot (immunoblot) system in comparison with an enzyme-linked immunosorbent assay and a different Western blot.

Authors:  B Weber; G Hess; R Enzensberger; F Harms; C J Evans; A Hamann; H W Doerr
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 3.  Antigen detection for human immunodeficiency virus.

Authors:  D J Harry; M B Jennings; J Yee; J R Carlson
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

4.  Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients.

Authors:  S K Arya; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.

Authors:  S L Josephson; N S Swack; M T Ramirez; W J Hausler
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.

Authors:  W G Robey; L O Arthur; T J Matthews; A Langlois; T D Copeland; N W Lerche; S Oroszlan; D P Bolognesi; R V Gilden; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus.

Authors:  M Morita; T Suzuki; K Nakajima; C Shiozawa; M J Gill; H Hoshino
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

8.  Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.

Authors:  Y Sei; P H Tsang; J P Roboz; P S Sarin; J I Wallace; J G Bekesi
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

9.  Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources.

Authors:  S Z Salahuddin; P D Markham; M Popovic; M G Sarngadharan; S Orndorff; A Fladagar; A Patel; J Gold; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

10.  Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III.

Authors:  L Ratner; B Starcich; S F Josephs; B H Hahn; E P Reddy; K J Livak; S R Petteway; M L Pearson; W A Haseltine; S K Arya
Journal:  Nucleic Acids Res       Date:  1985-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.